{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:37Z","timestamp":1753891957531,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The study aims to analyze the clinical characteristics of acute phase of SARS-CoV-2 infection in children aged 0\u201317 years with the Omicron variant, and summarize the persistent symptoms or new-onset clinical manifestations from 4 to 12 weeks after acute COVID. Explore the association between the vaccination status and SARS-CoV-2 neutralizing antibody levels post infection among preschool-aged children. The comprehensive study systematically describes the clinical characteristics of children infected with SARS-CoV-2, providing a foundation for diagnosis and evaluating long-term COVID in pediatric populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study enrolled children who were referred to the Children's Hospital, Capital Institute of Pediatrics, (Beijing, China) from January 10, 2023 to March 31, 2023. Participants were classified as infant and toddlers, preschool, school-age, and adolescent groups. Children or their legal guardians completed survey questionnaires to provide information of previous SARS-CoV-2 infection history, as well as clinical presentation during the acute phase and long-term symptoms from 4 to 12 weeks following infection. Furthermore, serum samples were collected from children with confirmed history of SARS-CoV-2 infection for serological testing of neutralizing antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study recruited a total of 2,001 children aged 0\u201317 years who had previously tested positive for SARS-CoV-2 through nucleic acid or antigen testing. Fever emerged as the predominant clinical manifestation in 1,902 (95.1%) individuals with body temperature ranging from 37.3 to 40.0\u00b0C. Respiratory symptoms were identified as secondary clinical manifestations, with cough being the most common symptom in 777 (38.8%) children, followed by sore throat (22.1%), nasal congestion (17.8%), and runnning nose (17.2%). Fatigue (21.6%), headache (19.8%) and muscle-joint pain (13.5%) were frequently reported systemic symptoms in children. The proportion of children with symptoms of SARS-CoV-2 infection varied across age groups. 1,100 (55.0%) children experienced persistent symptoms from 4 to 12 weeks post the acute phase of infection. Trouble concentrating (22.1%), cough (22.1%), and fatigue (12.1%) were frequently reported across age groups in the extended period. A limited number of children exhibited cardiovascular symptoms with chest tightness, tachycardia, and chest pain reported by 3.5%, 2.5%, and 1.8% of children, respectively. Among 472 children aged 3\u20135 years, 208 children had received two doses of SARS-CoV-2 vaccine at least 6 months prior to infection, and no association was found between the incidence of long-term COVID and pre-infection vaccination statuses among the 3\u20135 years age groups (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20091.136, <jats:italic>P<\/jats:italic>\u2009=\u20090.286).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In children aged 0\u201317 years infected with SARS-CoV-2 Omicron variant, fever was the primary clinical manifestation in the acute phase, followed by respiratory symptoms, systemic non-specific and digestive presentations. In particular, respiratory and digestive system symptoms were more frequent in children aged above 6 years. Regarding the long-term symptoms from 4 to 12 weeks post-infection, the most common presentations were concentrating difficulty, cough, and fatigue. The incidence of persistent symptoms of SARS-CoV-2 did not exhibit a significant correlation with vaccination status, which was attributed to the waning efficacy of the vaccine-induced humoral immune response after 6 months.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1332020","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:00:32Z","timestamp":1715749232000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical manifestations and long-term symptoms associated with SARS-CoV-2 omicron infection in children aged 0\u201317 years in Beijing: a single-center study"],"prefix":"10.3389","volume":"12","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenquan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jobb.2023.01.002","article-title":"Evolutionary analysis of omicron variant BF.7 and BA.5.2 pandemic in China","volume":"5","author":"Sun","year":"2023","journal-title":"J Biosaf Biosecur"},{"key":"B3","doi-asserted-by":"publisher","first-page":"990944","DOI":"10.3389\/fped.2022.990944","article-title":"Clinical characteristics of children with omicron SARS-CoV-2 infection in Changchun, China from march to April 2022: a retrospective study","volume":"10","author":"Li","year":"2022","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.arcped.2020.12.008","article-title":"COVID-19 infection in children: a systematic review and meta-analysis of clinical features and laboratory findings","volume":"28","author":"Mansourian","year":"2021","journal-title":"Arch Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2352-4642(22)00027-X","article-title":"Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study","volume":"6","author":"Cloete","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1093\/cid\/ciac275","article-title":"Coronavirus disease 2019 disease severity in children infected with the omicron variant","volume":"75","author":"Butt","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9950","DOI":"10.1038\/s41598-022-13495-5","article-title":"Long-COVID in children and adolescents: a systematic review and meta-analyses","volume":"12","author":"Lopez-Leon","year":"2022","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s00270-021-02832-2","article-title":"UK NICE guidelines for EVAR: cost implications for post-COVID Australian public health","volume":"44","author":"Clements","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"210185","DOI":"10.1183\/16000617.0185-202","article-title":"Post-acute COVID-19 syndrome","volume":"31","author":"Montani","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/archdischild-2021-32183","article-title":"WHO essential medicines for children 2011\u20132019: age-appropriateness of enteral formulations","volume":"107","author":"Orubu","year":"2022","journal-title":"Arch Dis Child"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 omicron variant in Southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12985-022-01873-4","article-title":"SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and omicron (B.1.1.529) variants era","volume":"19","author":"Khemiri","year":"2022","journal-title":"Virol J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e232328","DOI":"10.1001\/jamanetworkopen.2023.2328","article-title":"Pediatric emergency research Canada (PERC) COVID study group. Comparison of symptoms associated with SARS-CoV-2 variants among children in Canada","volume":"6","author":"Sumner","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3390\/children9121923","article-title":"Seizures in children with SARS-CoV-2 infection: epidemiological, clinical and neurophysiological characterization","volume":"9","author":"Pascarella","year":"2022","journal-title":"Children (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2227348","DOI":"10.1001\/jamanetworkopen.2022.27348","article-title":"Assessment of clinical and virological characteristics of SARS-CoV-2 infection among children aged 0 to 4 years and their household members","volume":"5","author":"Karron","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijid.2022.12.018","article-title":"The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts","volume":"128","author":"Westerhof","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e212025","DOI":"10.1001\/jamapediatrics.2021.2025","article-title":"Comparison of symptoms and RNA levels in children and adults with SARS-CoV-2 infection in the community setting","volume":"175","author":"Chung","year":"2021","journal-title":"JAMA Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","article-title":"Local and systemic responses to SARS-CoV-2 infection in children and adults","volume":"602","author":"Yoshida","year":"2022","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41587-021-01037-9","article-title":"Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children","volume":"40","author":"Loske","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jiph.2023.01.013","article-title":"Clinical and upper airway characteristics of 3715 patients with the omicron variant of SARS-cov-2 in Changchun, China","volume":"16","author":"Sha","year":"2023","journal-title":"J Infect Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"WHO clinical case definition working group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n136","article-title":"Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline","author":"Shah","year":"2021","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJMoa2203209","article-title":"Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age","volume":"387","author":"Tan","year":"2022","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101961","DOI":"10.1016\/j.eclinm.2023.101961","article-title":"Risk factors for post-COVID-19 condition (long COVID) in children: a prospective cohort study","volume":"59","author":"Morello","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/v14122629","article-title":"Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature","volume":"14","author":"Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S2352-4642(22)00154-7","article-title":"Long COVID symptoms in SARS-CoV-2-positive children aged 0\u201314 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study","volume":"6","author":"Berg S","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00431-021-04345-z","article-title":"Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study","volume":"181","author":"Borch","year":"2022","journal-title":"Eur J Pediatr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1030238","DOI":"10.3389\/fimmu.2022.1030238","article-title":"Post-vaccination SARS-CoV-2 seroprevalence in children aged 3\u201311 years and the positivity in unvaccinated children: a retrospective, single-center study","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of previous infection and vaccination on symptomatic omicron infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41591-022-01874-4","article-title":"Effectiveness of CoronaVac in children 3\u20135 years of age during the SARS-CoV-2 omicron outbreak in Chile","volume":"28","author":"Jara","year":"2022","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbi.2022.04.013","article-title":"Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections","volume":"103","author":"Taquet","year":"2022","journal-title":"Brain Behav Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review","volume":"53","author":"Notarte","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"104599","DOI":"10.1016\/j.ebiom.2023.104599","article-title":"Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents","volume":"92","author":"Ertesv\u00e5g","year":"2023","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1332020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:00:34Z","timestamp":1715749234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1332020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":34,"alternative-id":["10.3389\/fped.2024.1332020"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1332020","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"1332020"}}